Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tivic Health Systems (TIVC) Cash from Operations (2021 - 2025)

Historic Cash from Operations for Tivic Health Systems (TIVC) over the last 5 years, with Q3 2025 value amounting to -$2.0 million.

  • Tivic Health Systems' Cash from Operations fell 4257.14% to -$2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.0 million, marking a year-over-year increase of 221.9%. This contributed to the annual value of -$5.7 million for FY2024, which is 3273.41% up from last year.
  • Per Tivic Health Systems' latest filing, its Cash from Operations stood at -$2.0 million for Q3 2025, which was down 4257.14% from -$1.8 million recorded in Q2 2025.
  • Tivic Health Systems' 5-year Cash from Operations high stood at -$543000.0 for Q2 2021, and its period low was -$2.8 million during Q3 2022.
  • Moreover, its 5-year median value for Cash from Operations was -$1.8 million (2023), whereas its average is -$1.8 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first plummeted by 23082.71% in 2022, then skyrocketed by 4745.35% in 2024.
  • Over the past 5 years, Tivic Health Systems' Cash from Operations (Quarter) stood at -$2.8 million in 2021, then increased by 19.6% to -$2.2 million in 2022, then increased by 20.05% to -$1.8 million in 2023, then increased by 25.31% to -$1.3 million in 2024, then plummeted by 50.64% to -$2.0 million in 2025.
  • Its Cash from Operations was -$2.0 million in Q3 2025, compared to -$1.8 million in Q2 2025 and -$900000.0 in Q1 2025.